Clinical course and prognostic factors of childhood Takayasu’s arteritis: over 15-year comprehensive analysis of 101 patients

Table 1 Demographic, clinical, and therapeutic features of childhood Takayasu’s arteritis (c-TA)

	Median/n	IQR/%
Demographic features
Age at Takayasu’s arteritis onset, years	14	12–16
Delay to diagnosis/admission, years	0.6	0.2–2.1
BMI (kg/m²)	19.7	17.6–21.4
Sex (female)	77	76.2
Clinical presentations
Hypertension	71	70.3
Blood pressure discrepancy	56	55.4
Bruits	52	51.5
Pulse deficits	38	37.6
Dyspnea	30	29.7
Dizziness	27	26.7
Heart failure	25	24.8
Claudication	23	22.8
Fever	13	12.9
Syncope	10	9.9
Stroke	6	5.9
Carotidynia	4	4
Myocardial infarction/ischemia	3	3
Retinopathy	38	37.6
Direct inflammation involvement	20	19.8
Secondary to hypertension	17	16.8
Angiographic classification
Type I	12	11.9
Type IIa	0	0
Type IIb	10	9.9
Type III	9	8.9
Type IV	38	37.6
Type V	32	31.6
Laboratory results
Elevated ESR	33	32.7
Elevated CRP	35	34.7
Medications
Glucocorticoids	79	78.2
Immunosuppressant	11	10.9
Antiplatelet drugs	73	72.3
Antihypertensive drugs	73	72.3
Revascularization	58	57.4
Balloon angioplasty	41	40.6
Stenting	22	21.8
Surgery	8	7.9

BMI body mass index, CRP C-reactive protein, ESR erythrocyte sedimentation rate, IQR interquartile range

ISSN: 1478-6362